More on GBT
Data
Financials
News
Click line-items for a historical chart and %
| Revenue | 31.35M |
| Cost of Goods Sold | 17.93M |
| Gross Profit | 13.42M |
| Research and development expenses | 298.26K |
| Selling, general and administrative expenses | 2.08M |
| Operating income | 11.04M |
| Interest income | 112.17K |
| Interest (expense) | 0 |
| Other income | 24.82K |
| Foreign currency transaction (loss) | -90.68K |
| Change in fair value of warrants | 2.19M |
| Total other income | 2.24M |
| Equity gain (loss) from unconsolidated entity | -923 |
| Income before Income Taxes | 13.28M |
| Income tax expense | 3.01M |
| Net income | 10.27M |
| Foreign currency translation adjustment | 3.45M |
| Comprehensive Income | 13.72M |
| Earnings per share - basic | 0.13 |
| Earnings per share - diluted | 0.12 |
| Weighted average number of common shares outstanding - basic | 76.44M |
| Weighted average number of common shares outstanding - diluted | 82.61M |
Entities mentioned with GBT
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Pre Market Movers | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- IPO | View Related Stories »
- Show More...
